Ascend Wellness (OTCMKTS:AAWH – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.13) by ($0.01), Zacks reports.
Here are the key takeaways from Ascend Wellness’ conference call:
- Third-quarter net revenue rose 3.1% sequentially and 4.2% year over year to $130 million; Adjusted EBITDA increased 7% sequentially to $31.1 million, with margin expanding to 23.9%. Operating cash flow was positive at $5.4 million despite a $19.1 million interest payment.
- Ascend reached 61 stores after quarter-end, ahead of its 60-store target, and retail sales grew 5.5% sequentially to 75.2% of revenue. Transactions hit a company record, while management said new stores and further acquisitions remain central to its expansion strategy.
- Management reported cultivation yields up 21% since the first quarter of 2025, alongside improved premium-flower output and product quality. It also cited brand strength across core markets and plans to begin licensing select products in Canada in early 2027.
- For the fourth quarter, management expects only 1%–2% top-line growth and Adjusted EBITDA margin roughly in line with Q3, citing seasonal discounting, continued price compression, and the time required for new stores to ramp.
- Wholesale revenue fell 3.6% sequentially, largely due to the July Illinois work stoppage, though September was the channel’s strongest month of the quarter. Management said the broader shift toward retail is intentional, as it reduces reliance on wholesale and supports higher margins.
Ascend Wellness Stock Down 4.3%
AAWH opened at $0.35 on Friday. The stock has a market cap of $71.10 million, a PE ratio of -0.61 and a beta of 1.22. Ascend Wellness has a 52 week low of $0.34 and a 52 week high of $1.20. The business’s fifty day simple moving average is $0.46 and its 200 day simple moving average is $0.49.
About Ascend Wellness
Ascend Wellness Holdings is a U.S. cannabis company that cultivates, processes, and sells cannabis products in regulated state markets. Its business combines cultivation and manufacturing facilities with a network of retail dispensaries. The company offers products including cannabis flower, edibles, concentrates, and vape products. Its portfolio includes brands such as Ozone and Simply Herb, alongside products from other suppliers sold through its retail stores. Founded in 2018, Ascend has developed operations across markets including Illinois, Michigan, Ohio, Massachusetts, New Jersey, and Pennsylvania.
Read More
- Five stocks we like better than Ascend Wellness
- Heavy Lifting: Can USA Rare Earth Turn Its First Sales Into Big Profits?
- These 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?
- Golden Dome’s $185 Billion Question: Who Actually Gets Paid?
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
Receive News & Ratings for Ascend Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascend Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
